[1] 黄宇星,刘二伟. 联合用药的药物相互作用及研究方法.药物评价与研究,2014,37:276-279.
[2] 孙雨平,史国兵,樊蓉,等.他克莫司致不良反应67例文献分析.医药导报,2014,33:1535-1537.
[3] 王艳飞,石红娟,尹博英,等.双环醇预防他汀类药物肝损害的临床疗效观察.实用心脑肺血管病杂志,2013, 21:132-133.
[4] Lou XE, Xu N, Yao HP, et al. Bicyclol attenuates pro-inflammatory cytokine and chemokine productions in CpG-DNA-stimulated L02 hepatocytes by inhibiting p65-NF-kappa B and p38-MAPK activation. Pharmazie,2010,65: 206-212.
[5] Yu YN, Chen H, Li Y. Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice. Basic Clin Pharmacol Toxicol,2009,104:300-305.
[6] Liu GT, Li Y, Wei HL, et al. Mechanism of protective action of bicyclol against CCl-induced liver injury in mice. Liver Int,2005,25: 872-879.
[7] Li X, Zhou J, Chen S, et al. Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer. J Int Med Res,2014,42:906-914.
[8] Chu NH, Li L, Zhang X, et al. Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease.Int J Tuberc Lung Dis,2015,19:475-480.
[9] 杨树,赵曼曼,扈金萍,等.双环醇对二甲双胍、非诺贝特、环孢素A、他克莫司药物体外代谢的影响.胃肠病学和肝病学杂志,2015,24:1500-1504.
[10] de Jonge H, de Loor H,Verbeke K, et al. Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism. Pharmacogenomics,2013,14:1467-1480. |
